Washington: The White House’s big pharma deal
The Takeaway’s Washington correspondent, Todd Zwillich, joins us with a look at a deal the White House reached earler this year with drug companies. The deal stipulated that pharmaceutical companies would cut name-brand drug prices by 50% for seniors who aren’t covered under Medicare’s drug plan. In exchange, the White House promised no further cuts to the pharmaceutical industry. While both the White House and Sen. Max Baucus (D-Mont.) want to honor the deal, some Democrats are appalled by the seeming kowtowing to special interests.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!